PURPOSE: To determine the changes in clinical trials and outcomes of patients with
advanced-stage non–small-cell lung cancer (NSCLC) treated on phase III randomized trials …

抄録< jats: sec>< jats: title> PURPOSE</jats: title>< jats: p> The primary objective was to
determine clinical practice guidelines for the diagnostic evaluation, treatment, and follow-up …

The purpose of this article is to provide updated recommendations for the treatment of
patients with stage IV non–small-cell lung cancer. A literature search identified relevant …

PURPOSE To estimate the impact of chemotherapy on survival of patients with advanced
non-small-cell lung cancer (NSCLC). METHODS Randomized controlled trials (RCTs) …

The survival benefit of combination chemotherapy to patients with advanced non-small-cell
carcinoma of the lung (NSCLC) is controversial. To study this question, the National Cancer …

For patients with advanced non-small cell lung cancer and a good functional status,
platinum-based first-line chemotherapy improves quality of life, reduces disease-related …

Background: For many years, high-dose radiation therapy was the standard treatment for
patients with locally or regionally advanced non-small-cell lung cancer (NSCLC), despite a 5 …

PURPOSE: To compare four cycles of therapy versus continuous therapy to determine the
optimal duration of chemotherapy in advanced non–small-cell lung cancer (NSCLC) …

PURPOSE: A key challenge in the treatment of advanced non-small-cell lung cancer
(NSCLC) is improving outcomes for patients who have achieved at least stable disease after …

This well-conducted review concluded that extension of chemotherapy, particularly with a
third-generation regimen, substantially improved progression-free survival and had a lesser …